The therapeutic relevance of a BRCA2 mutation in a patient with recurrent thymoma: a case report

BACKGROUND: Thymomas are characterized by a low tumor mutation burden and a paucity of actionable mutations. Clinical behavior can vary from relatively indolent to very aggressive and impact survival. Platinum-based chemotherapy is the primary treatment modality for inoperable disease and is palliat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sigurdson, Samantha, Marom, Edith M., Rimner, Andreas, Shepherd, Annemarie, Szolkowska, Malgorzata, Roden, Anja C., Marino, Mirella, Tomiyama, Noriyuki, Ball, David, Falkson, Conrad, Rajan, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792822/
https://www.ncbi.nlm.nih.gov/pubmed/36582974
http://dx.doi.org/10.21037/med-22-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792822/
https://www.ncbi.nlm.nih.gov/pubmed/36582974
http://dx.doi.org/10.21037/med-22-9

Ejemplares similares